10/14 RegenMD

RegenMD         Mesoblast Limited (ASX:MSB) Targets Broader Cancer Indications For Bone Marrow ... October 13, 2010 at 7:34 PM   Melbourne, Australia, Oct 14, 2010 (ABN Newswire via COMTEX) -- Australian regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today ... See all stories on this topic »         Perfect BioTiming! October 13, 2010 at 5:52 PM   It is also, however, an important milestone in the maturation of regenerative medicine. I expect the entire industry to benefit from this agreement. ... See all stories on this topic »         NIH Award Advances Research on Optimizing Cardiovascular Devices October 13, 2010 at 2:56 PM   Areas of research emphasis include Biomechanics & Biomaterials, Bioelectricity & Bioimaging, Tissue Engineering, Bioinstrumentation and Biosignal Processing ...         Holding on to cells with DNA October 13, 2010 at 12:21 PM   Tissue engineering aims to make three dimensional, biodegradable scaffolds that cultured cells can grow on to form body parts, like the ear-shaped bit of ...         Cytori Announces Exercise in Full of Overallotment Option and Closing of ... October 13, 2010 at 11:33 AM   Cytori develops and commercializes medical technologies that enable the practice of regenerative medicine. This press release includes forward-looking ... See all stories on this topic »         SBU Biomedical Engineering Professor Receives NIH New Innovator ... October 13, 2010 at 10:33 AM   Dr. Sitharaman's proposed technology applies bone tissue engineering strategies and harnesses the physical properties of multifunctional nanonmaterials, ... Nanotechnology News         Lipid profile components and risk of ischemic stroke: a role for the pleiotropic effects of statins. October 13, 2010 at 10:25 AM   Lipid profile components and risk of ischemic stroke: a role for the pleiotropic effects of statins. Arch Neurol. 2010 Oct;67(10):1284-5 Authors: Connick P, Stacpoole SR PMID: 20937963 [PubMed - in process]         Roger Kamm elected to the Institute of Medicine October 13, 2010 at 9:40 AM   Current research activities in Kamm's laboratory can be grouped into three broad categories: tissue engineering and microfluidics, cellular rheology and ... MIT News         Blue-Ribbon Panel Hears Recommendations for More Openness at California Stem Cell Agency October 13, 2010 at 6:43 AM         Public Still Barred from Sweeping CIRM Review October 13, 2010 at 3:39 AM         Stem cell research group pulls 'blasphemous' poem October 13, 2010 at 2:16 AM   The California Institute for Regenerative Medicine has been sparring with the Life Legal Defense Fund since the publicly funded agency was approved by ... See all stories on this topic »         Cytori Therapeutics prices common stock offering October 13, 2010 at 12:57 AM   (Source: Datamonitor)Cytori Therapeutics, a regenerative medicine company, is selling four million shares of its common stock at a price to the public of ... See all stories on this topic »             This email was sent to regenmd@gmail.com. Delivered by Feed My Inbox 230 Franklin Road Suite 814 Franklin, TN 37064 Account Login Unsubscribe Here